Nippon Shinyaku Co Ltd NPNKF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $23.74
- Day Range
- $23.50–23.50
- 52-Week Range
- $21.00–38.01
- Bid/Ask
- $19.65 / $23.80
- Shares Outstanding
- 67.40M
- Market Cap
- $1.58B
- Volume/Avg
- 51,680 / 24,940
Key Statistics
- Price/Earnings (Normalized)
- 7.88
- Price/Sales
- 1.36
- Dividend Yield (Trailing)
- 3.31%
- Dividend Yield (Forward)
- 3.33%
- Dividend Payment Schedule
- Jun, Dec
- Total Yield
- 3.31%
Company Profile
Nippon Shinyaku Co Ltd is engaged in the pharmaceuticals and functional food businesses. The Pharmaceuticals Business develops and sells treatments for urological disorders, blood cancer, rare and intractable diseases, and gynecological conditions. The Functional Food Business produces and sells health food ingredients, quality-stabilizing preservatives, protein preparations, and supplements. It generates the majority of its revenue from the Pharmaceuticals segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,309
Valuation
|
Metric
|
NPNKF
|
|---|---|
Price/Earnings (Normalized) | 7.88 |
Price/Book Value | 0.87 |
Price/Sales | 1.36 |
Price/Cash Flow | 7.64 |
Price/Earnings
NPNKF
Financial Strength
|
Metric
|
NPNKF
|
|---|---|
Quick Ratio | 3.19 |
Current Ratio | 4.66 |
Interest Coverage | 234.32 |
Quick Ratio
NPNKF
Profitability
|
Metric
|
NPNKF
|
|---|---|
Return on Assets (Normalized) | 9.20% |
Return on Equity (Normalized) | 10.70% |
Return on Invested Capital (Normalized) | 10.24% |
Return on Assets
NPNKF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|?%Pr&^q | LOCK|F#>P% | $71B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|t#<?DhS | LOCK|FtFM? | $47B | |||
| Haleon PLC ADR
HLN
| LOCK|Znq#@W& | LOCK|k! | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|^>%cFBz | LOCK|&@ | $34B | |||
| Viatris Inc
VTRS
| LOCK|^n>pP$p | LOCK|L@s | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|@c# | LOCK|klv | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|qm@?^sp | LOCK|v^ | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|>x&hJ@< | LOCK|?b | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|$<?vC# | LOCK|!>GW> | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|<>C&b> | LOCK|RV | $2B |
United States